US Patent Issued to POROSOME THERAPEUTICS on Feb. 18 for "Aerosol and topical administration of a formulation containing cyclodextrin, quercetin and zinc, in combination or separately, to mitigate infection by enveloped viruses" (Michigan Inventor)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,431, issued on Feb. 18, was assigned to POROSOME THERAPEUTICS INC. (Boston).

"Aerosol and topical administration of a formulation containing cyclodextrin, quercetin and zinc, in combination or separately, to mitigate infection by enveloped viruses" was invented by Bhanu Pratap Jena (Bloomfield Hills, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides the use of a formulation containing cyclodextrine, quercetin and zinc, at appropriate concentrations to mitigate infections by enveloped viruses like SARS-COV-2, influenza and HIV/AIDS, when administered via pulmonary and dermal route. While the different forms of cyclodextrin p...